investordatabase.org

Synapses Ventures

synapsesventures.com Direct investor

Synapses Ventures is a Silicon Valley venture-building company that builds companies from the ground up and backs founders with capital and operational support. It focuses on AI, healthcare, fintech and education ventures.

Synapses Ventures is a venture studio headquartered in Menlo Park, United States. It invests directly in companies, in AI, healthcare, FinTech and education.

“We partner with ambitious founders to validate, build, fund, and scale breakthrough companies through technology, strategic capital, operational expertise, and a global innovation network.”

— Synapses Ventures, own website
Layer
Direct investor
Type
Venture studio
Stage
Not stated
Headquarters
Menlo Park, United States
Invests in
Silicon Valley, global
Sectors
AI, Healthcare, FinTech, Education, MedTech

Team, as Synapses Ventures publishes it

  • Murat Baday, PhD Founder
  • Kerry Brown Partner | Entrepreneur & Growth Advisor
  • Nahid Fattahi Partner | Global Strategy & International Expansion
  • Daniel Chatelain Partner | Innovation & Business Development
  • Elif Sare Koytak, MD Internal Medicine | Medical Entrepreneur
  • John Cabri Partner | Executive Advisor
  • Jagriti Jaiswal Partner | Healthcare Innovation
  • Danny Seth Partner, Investments
  • Mücteba Acar Venture Partner
  • Promita Chakraborty, PhD AI/ML & Multimodal Data Science

Names and roles exactly as listed on synapsesventures.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Synapses Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://synapsesventures.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, thesis_quote, description, people, status

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 14762 · added 2026-10-20 · link last verified 2026-10-21 · confidence medium

Similar investors

Listed under